ABSTRACT -A 42 year-old woman developed paraplegia that resolved in six months, followed by sudden right hemiparesis and dysphasia two years later. The clinical work-up, including CT and MR scans, visual evoked potentials, CSF examination and cerebral biopsy suggested the posibility of either multiple sclerosis or multiphasic disseminated encephalomyelitis. The differential diagosis between both conditions is discussed.
CASE REPORT
A 42 year-old right handed white woman was seen as an outpatient in July 199S because of right hemiparesis and dysphasia for IS days. Two years earlier she suddenly presented paraplegia together with hypoesthesia up to D4 level, bladder and retal dysfunction. The diagnosis of transverse myelitis was given elsewhere and she was treated with oral corticosteroids. She became able to walk with assistance within two months. Six months later the patient became fully recovered except for urinary retention. For the last six months she noticed intermittent diplopia and one week earlier she had developed paroxysm of vertigo and "Jabs-like" headache. A right hemiparesis with hyperreflexia and Babinski sign were present, as well as motor dysphasia and marked pallor of both optic discs. Systemic examination was normal. She reported hemorrhoids and an uterine myoma surgery fifteen years earlier. Her medical history was otherwise unremarkable. There was no history of previous infection or recent immunization against rabies, measles or influenza.
The routine laboratory screaning was normal. A CT brain scan and a RMI (Fig 1) showed ring-like enhancing lesions with oedema in the right and left fronto-parietal lobes, and in the left occipital lobe. Visual evoked potentials and the CSF were normal, without oligoclonal bands or IgG increase. A CSF anti-HIV test was negative.
A needle biopsy of the right fronto-parietal lobe lesion was carried out showing inflammatory primary demyelination without evidence of malignancy.
She was given oral dexametazone 4 mg qid. One-and-half month later speech and strenght were normal. A control MR taken 2.5 months after the first MR, showed great improvement (Fig 2) . There has been a considerable reduction of the right side lesion while the two largest lesions on the left side almost disappeared.
DISCUSSION

Enhancing lesions with mass efect have been associated with MS
1 -6,7,10 . As far as the MR is concerned, the present patient fulfills the criteria for the "strongly suggestive of MS" category" with three lesions hyperintense in T2 longer than 3.0 mm, one of which being periventricular. She also fulfills the criteria for clinically definite MS (CDMS) 14 as there were two attacks, clinical and paraclinical evidence supporting two separate lesions. Besides, the two attacks involved different parts of the CNS, occurred more than a month appart and lasted more than 24 hours each. It is generally recognized that the diagnosis of CDMS has an accuracy of 90 to 95%". Acute transverse myelopathy may occur in both MS and DEM. It is generally accepted that acute transverse myelopathy without associated neurologic signs or symptoms is a manifestation of DEM in 75% to 80% of cases 13 .
Monophasic acute DEM, the so-called ADEM, is not difficult to differentiate from MS since the diagnosis of MS should never be based on a single episode. Poser 12 proposed that DEM may be divided into two types. In the first type (recurrent DEM-RDEM), an initial episode of ADEM is followed by one or more episodes that reproduce all or some of the symptoms of the original attack.This presentation form is rare in MS. In the second type, there are two or more separate clinically different acute episodes (multiphasic-MDEM).
Any MS clinical feature may be present in encephalomyelitis and vice-versa 9 . Therefore, it is impossible to differentiate MDEM from MS on clinical grounds. This differentiation is nevertheless important since the prognosis of MDEM is comparatively better 4 Whether influenza virus vaccine produces a form of ADEM or precipitates attacks of MS is an unsolved question. Until now, it is still far from whether ADEM and MS represent distinct disease entities or simply two different clinical expressions of the same reactive process 16 .
